Dr. Danzig is VP, Clinical Development and Medical Affairs. She joined PaxVax in early 2015 as a Special Advisor for Clinical and Medical Affairs, following 18 years with Novartis Vaccines and Diagnostics, most recently as Global Head of Medical & Scientific Affairs, Diagnostics (acquired by Grifols).
Dr. Danzig has contributed to the development of meningococcal vaccines (Menjugate®, Menveo® and Bexsero®) and has worked in Siena, Italy, Cambridge, MA and Hangzhou, China. During her two years as an EIS officer with the Centers for Disease Control and Prevention, she investigated outbreaks of healthcare-associated infections and taught epidemiology in Cote d’Ivoire to district health officers in West Africa.
Dr. Danzig received her medical degree from Oregon Health Sciences University and completed residency and fellowship training in Internal Medicine and Infectious Diseases in San Francisco. She is an independent director at OrSense, and serves on the boards of the Sustainable Sciences Institute and the Karuna Foundation and is an advisor to the Lemelson Foundation, and Kernel.